Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trial.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Respiratory Medicine

• Publication date

  2009-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.rmed.2009.01.019PMID 19249198
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of add-on montelukast in patients with non-controlled asthma: a Belgian open-label study*

  2009cited by this paper
• Efficacy of add-on montelukast in patients with non-controlled asthma: a Belgian open-label study.

  2009cited by this paper
• The demise of anti IL-5 for asthma, or not.

  2007cited by this paper
• Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma

  2007cited by this paper
• Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design

  2006cited by this paper
• The expanding role of leukotriene receptor antagonists in chronic asthma.

  2006cited by this paper
• Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade.

  2006cited by this paper
• Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge.

  2006cited by this paper
• Effect of montelukast on exhaled leukotrienes and quality of life in asthmatic patients.

  2005cited by this paper
• Inter‐relationships between airway inflammation, reticular basement membrane thickening and bronchial hyper‐reactivity to methacholine in asthma; a systematic bronchoalveolar lavage and airway biopsy analysis

  2005cited by this paper
• Localization and upregulation of cysteinyl leukotriene-1 receptor in asthmatic bronchial mucosa.

  2005cited by this paper
• Effect of montelukast compared with inhaled fluticasone on airway inflammation

  2004cited by this paper
• The role of leukotrienes in asthma.

  2003cited by this paper
• Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling.

  2003cited by this paper
• Methods for the assessment of endobronchial biopsies in clinical research: application to studies of pathogenesis and the effects of treatment.

  2003cited by this paper
• Variation of CD8+ T‐lymphocytes around the bronchial internal perimeter in chronic bronchitis

  2003cited by this paper
• Anti-leukotrienes as novel anti-inflammatory treatments in asthma.

  2002cited by this paper
• Cysteinyl leukotrienes promote human airway smooth muscle migration.

  2002cited by this paper
• The roles of leukotrienes and the effects of leukotriene receptor antagonists in the inflammatory response and remodelling of allergic asthma

  2001cited by this paper
• Remodeling in asthma and chronic obstructive lung disease.

  2001cited by this paper
• Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes.

  2001cited by this paper
• Leukotriene inhibitors and non-steroidal therapies in the treatment of asthma

  2001cited by this paper
• On estimation of the Poisson parameter in zero-modified Poisson models

  2000cited by this paper
• Asthma. From bronchoconstriction to airways inflammation and remodeling.

  2000cited by this paper
• Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group.

  1999cited by this paper
• The effect of montelukast (MK‐0476), a cysteinyl leukotriene receptor antagonist, on allergen‐induced airway responses and sputum cell counts in asthma

  1999cited by this paper
• Characterization of the human cysteinyl leukotriene CysLT1 receptor

  1999cited by this paper
• Montelukast, a leukotriene receptor antagonist, reduces the concentration of leukotrienes in the respiratory tract of children with persistent asthma.

  1999cited by this paper
• Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial.

  1999cited by this paper
• Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group.

  1999cited by this paper
• Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group.

  1999cited by this paper
• Histamine and the antiallergic antihistamines: a history of their discoveries

  1999cited by this paper
• Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics.

  1999cited by this paper
• The zero‐inflated Poisson model and the decayed, missing and filled teeth index in dental epidemiology

  1999cited by this paper
• Montelukast for Chronic Asthma in 6- to 14-Year-Old Children A Randomized, Double-blind Trial

  1998cited by this paper
• Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.

  1998cited by this paper
• Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma

  1998cited by this paper
• Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction In vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists.

  1998cited by this paper
• Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge.

  1998cited by this paper
• Variation in the measurements of basement membrane thickness and inflammatory cell number in bronchial biopsies.

  1998cited by this paper
• Myofibroblast involvement in the allergen-induced late response in mild atopic asthma.

  1997cited by this paper
• Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa.

  1996cited by this paper
• Intrasubject variability in airway inflammation in biopsies in mild to moderate stable asthma.

  1996cited by this paper
• The importance of leukotrienes in airway inflammation in a mouse model of asthma

  1996cited by this paper
• Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma.

  1995cited by this paper
• Regular albuterol, nedocromil sodium, and bronchial inflammation in asthma.

  1995cited by this paper
• Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma.

  1994cited by this paper
• Leukotriene E4 and granulocytic infiltration into asthmatic airways.

  1993cited by this paper
• Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness.

  1992cited by this paper
• Zero-inflated Poisson regression, with an application to defects in manufacturing

  1992cited by this paper
• Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study.

  1992cited by this paper

• Narrative review: Chronic lung allograft dysfunction with focus on short telomere syndrome, adjunctive therapies, and MRI detection

  2025cites this paper
• Mast cell metabolism in cancer: an underexplored frontier demanding more attention

  2025cites this paper
• Pediatric Asthma: Where Has Montelukast Gone?

  2023cites this paper
• Treatments for poorly controlled asthma

  2021cites this paper
• Follow-up on the therapeutic effects of a budesonide, azithromycin, montelukast, and acetylcysteine (BAMA) regimen in children with post-infectious bronchiolitis obliterans

  2021cites this paper
• Potential antiviral and anti-inflammatory role of Montelukast in viral infections including SARS-CoV-2 Infection (COVID19) – A Descriptive review

  2020cites this paper
• Successful management of refractory cough with the leukotriene receptor antagonist zafirlukast in a dog with chronic bronchitis: a case report

  2018cites this paper
• Phenotyping patients with chronic cough: Evaluating the ability to predict the response to anti-inflammatory therapy.

  2018cites this paper
• Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial

  2018cites this paper
• Comparison between montelukast and tiotropium as add-on therapy to inhaled corticosteroids plus a long-acting β2-agonist in for patients with asthma

  2018cites this paper
• Understanding shared pathogenesis between chronic obstructive pulmonary disease (COPD) and lung cancer by means of cell specific genomics

  2018cites this paper
• Prevention of chronic rejection after lung transplantation.

  2017cites this paper
• The emerging role of the eosinophil and its measurement in chronic cough : airway inflammation in chronic cough

  2017cites this paper
• The Emerging Role of The Eosinophil and Its Measurement in Chronic Cough

  2017cites this paper
• Regulation of Eosinophil and Group 2 Innate Lymphoid Cell Trafficking in Asthma

  2017cites this paper
• Inflammatory markers as exacerbation risk factors after asthma therapy switch from inhaled steroids to montelukast.

  2016cites this paper
• Bronchoprotection and bronchorelaxation in asthma: New targets, and new ways to target the old ones.

  2016cites this paper
• Inflammatory Mediators and Neuromodulators: Targeting in Asthma and Chronic Obstructive Pulmonary Disease

  2016cites this paper
• Lipid Mediators and Lung Function

  2015cites this paper
• Anti-atherosclerotic Potentials of Montelukast in Chronic Ovalbumin Challenged Asthmatic Guinea Pigs Fed High Fat Diet : A Comparative Study with Fluticasone

  2014cites this paper
• A review on leukotrienes and their receptors with reference to asthma

  2013cites this paper
• Inhaled corticosteroids and leukotriene modifiers as mono-therapy for mild persistent asthma

  2013cites this paper
• Effects of add-on montelukast on airway hyperresponsiveness in patients with well-controlled asthma – a pilot study

  2013cites this paper
• Eosinophils Induce Airway Smooth Muscle Cell Proliferation

  2013cites this paper
• Montelukast in asthma: a review of its efficacy and place in therapy

  2011cites this paper
• Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study

  2011cites this paper
• Influência do montelucaste sobre o estado de ativação dos eosinófilos e função dos fagócitos em crianças asmáticas

  2010cites this paper
• Anti-inflammatory effects of montelukast on smoke-induced lung injury in rats

  2010cites this paper
• Cysteinyl Leukotrienes and Their Receptors: Molecular and Functional Characteristics

  2010cites this paper
• Montelukast: Pharmacology, Safety, Tolerability and Efficacy

  2009cites this paper
• Additional effects of pranlukast in salmeterol/fluticasone combination therapy for the asthmatic distal airway in a randomized crossover study.

  2009cites this paper
• Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.

  2009cites this paper